retatrutide fda status for Weight Loss: TRIUMPH-1 Results, Cost, Insurance Some Providers Prescribe Unapproved Retatrutide

(NEJM, 2023) reported a mean body weight reduction of approximately 24% at 48 weeks

GLP-1 drugs Bariatric surgery remains the most effective option for long-term weight loss in appropriately selected patients

Aside from a stool or microbiome test, several signs may indicate low Akkermansia levels and the need for supplementation: Metabolic dysfunction: Struggles with blood sugar balance, weight, food cravings, brain fog, post-meal slump, or chronic inflammation may point to metabolic dysfunction

"We ask the question, do we need to change the dose

Think of it as easing into cool water instead of jumping in

The FDA's evolving stance on compounded GLP-1 medications is an ongoing consideration